MaineLD 178132nd Maine Legislature (2025-2026)HouseWALLET

An Act Regarding Coverage for Step Therapy for Metastatic Cancer

Sponsored By: Kristi Mathieson (Democratic)

Signed by Governor

INSURANCEINSURANCE - HEALTH INSURANCE

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

No step therapy for metastatic cancer drugs

Beginning July 1, 2025, insurers and their reviewers cannot require step therapy before covering certain cancer drugs. If you have metastatic cancer or related conditions, they must cover an FDA-approved drug on the plan’s formulary without making you try other drugs first. This applies to Maine-regulated health plans.

Defines metastatic cancer and related conditions

Starting July 1, 2025, the law defines metastatic cancer as cancer that has spread from its original site. It also defines associated conditions as symptoms or side effects of metastatic cancer or its treatment that would harm a patient if left untreated, as judged by the clinician. These definitions guide coverage and review decisions for Maine health plans.

Sponsors & Cosponsors

Sponsor

  • Kristi Mathieson

    Democratic • House

Cosponsors

  • Denise Tepler

    Democratic • Senate

  • Sally Cluchey

    Democratic • House

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Signed by Governor, ACTPUB Chapter 448

    7/1/2025
  2. On motion by Senator ROTUNDO of Androscoggin taken from the Special Appropriations Table PASSED TO BE ENACTED in concurrence.

    6/25/2025Senate
  3. On motion by Senator ROTUNDO of Androscoggin PLACED ON THE SPECIAL APPROPRIATIONS TABLE pending ENACTMENT in concurrence.

    6/2/2025Senate
  4. PASSED TO BE ENACTED. Sent for concurrence. ORDERED SENT FORTHWITH.

    5/29/2025House
  5. Report READ and ACCEPTED, in concurrence.READ ONCE.Committee Amendment "A" (H-272) READ and ADOPTED, in concurrence.Under suspension of the Rules, READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED BY Committee Amendment "A" (H-272), in concurrence.Ordered sent down forthwith.

    5/28/2025Senate
  6. CONSENT CALENDAR - FIRST DAYUnder suspension of the rules CONSENT CALENDAR - SECOND DAY.The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (H-272).Sent for concurrence. ORDERED SENT FORTHWITH.

    5/27/2025House
  7. Carried over, in the same posture, to the next special or regular session of the 132nd Legislature, pursuant to Joint Order SP 519.

    3/21/2025House
  8. The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES in concurrence

    1/14/2025Senate
  9. Committee on Health Coverage, Insurance and Financial Services suggested and ordered printed. The Bill was REFERRED to the Committee on HEALTH COVERAGE, INSURANCE AND FINANCIAL SERVICES.Sent for concurrence. ORDERED SENT FORTHWITH.

    1/14/2025House

Bill Text

  • Amendment C-A (H-272), adopted by House & Senate

  • Enacted

  • Introduced

Related Bills

Back to State Legislation